Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis

Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis

Highlights • We investigate the impact of low-level laser therapy on the OS, DFS, PFS. • We report data suggesting that morbidity was lower in the Laser Group. • The LLLT had a positive impact on the response to cancer treatment and on PFS.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral oncology 2017-08, Vol.71, p.11-15
Hauptverfasser: Antunes, Héliton S, Herchenhorn, Daniel, Small, Isabele A, Araújo, Carlos M.M, Viégas, Celia Maria Pais, de Assis Ramos, Gabriela, Dias, Fernando L, Ferreira, Carlos G
Format: Artikel
Sprache:eng
Schlagworte:
Chemoradiotherapy
Chemotherapy
Disease-free survival
Female
Head and neck cancer
Head and Neck Neoplasms - therapy
Hematology, Oncology and Palliative Medicine
Humans
Low-level laser therapy
Low-Level Light Therapy
Male
Middle Aged
Oral mucositis
Otolaryngology
Overall survival
Progression-free survival
Radiotherapy
Stomatitis - prevention & control
Survival Analysis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • We investigate the impact of low-level laser therapy on the OS, DFS, PFS. • We report data suggesting that morbidity was lower in the Laser Group. • The LLLT had a positive impact on the response to cancer treatment and on PFS.
ISSN:1368-8375
1879-0593
DOI:10.1016/j.oraloncology.2017.05.018